November
9, 2006
Filed under Rule 433
Registration Nos. 333-72546 and 333-118186
Pricing Term Sheet
| Issuer: | Merck & Co., Inc. | |
| Size: | $250,000,000 | |
| Title: | 5 1/8% Notes due 2011 | |
| Maturity: | November 15, 2011 | |
| Coupon: | 5 1/8% | |
| Price to Public: | 99.860% of face amount | |
| Yield to maturity: | 5.157% | |
| Spread to Benchmark Treasury: | 55 basis points | |
| Benchmark Treasury: | 4 5/8% due October 31, 2011 | |
| Benchmark Treasury Spot and Yield: | 100-2+ and 4.607% | |
| Proceeds (Before Expenses) to Issuer: | $249,650,000 | |
| Interest Payment Dates: | May 15 and November 15, commencing on May 15, 2007 | |
| Redemption Provisions: | ||
Make-Whole Call: |
T + 10 basis points | |
| Trade Date: | November 9, 2006 | |
| Settlement Date: | November 14, 2006 (T+3) | |
| CUSIP: | 589331 AL 1 | |
| ISIN: | US589331AL15 | |
| Denominations: | $2,000 minimum and $1,000 in excess thereof | |
| Moody's: Aa3, outlook negative | ||
| S&P: AA–, outlook negative | ||
| Ratings: | ||
| Joint Bookrunning Managers: | Credit Suisse Securities (USA) LLC Goldman, Sachs & Co. |
|
| Co-Managers: | Banc of America Securities LLC Citigroup Global Markets Inc. J.P. Morgan Securities Inc. Merrill Lynch, Pierce, Fenner & Smith Incorporated Morgan Stanley & Co. Incorporated |
The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling Goldman, Sachs & Co. toll free 1-877-471-2526 or Credit Suisse Securities (USA) LLC toll free 1-800-221-1037.
November
9, 2006
Filed under Rule 433
Registration Nos. 333-72546 and 333-118186
Pricing Term Sheet
| Issuer: | Merck & Co., Inc. | |
| Size: | $500,000,000 | |
| Title: | 5 3/4% Notes due 2036 | |
| Maturity: | November 15, 2036 | |
| Coupon: | 5 3/4% | |
| Price to Public: | 99.518% of face amount | |
| Yield to maturity: | 5.784% | |
| Spread to Benchmark Treasury: | 105 basis points | |
| Benchmark Treasury: | 4 1/2% due February 15, 2036 | |
| Benchmark Treasury Spot and Yield: | 96-10 and 4.734% | |
| Proceeds (Before Expenses) to Issuer: | $497,590,000 | |
| Interest Payment Dates: | May 15 and November 15, commencing on May 15, 2007 | |
| Redemption Provisions: | ||
| Make-Whole Call: | T + 20 basis points | |
| Trade Date: | November 9, 2006 | |
| Settlement Date: | November 14, 2006 (T+3) | |
| CUSIP: | 589331 AM 9 | |
| ISIN: | US589331AM97 | |
| Denominations: | $2,000 minimum and $1,000 in excess thereof | |
| Moody’s: Aa3, outlook negative | ||
| S&P: AA–, outlook negative | ||
| Ratings: | ||
| Joint Bookrunning Managers: | Credit Suisse Securities (USA) LLC Goldman, Sachs & Co. |
|
| Co-Managers: | Banc of America Securities LLC Citigroup Global Markets Inc. J.P. Morgan Securities Inc. Merrill Lynch, Pierce, Fenner & Smith Incorporated Morgan Stanley & Co. Incorporated |
The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling Goldman, Sachs & Co. toll free 1-877-471-2526 or Credit Suisse Securities (USA) LLC toll free 1-800-221-1037.